Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Mustang Bio's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $27.44M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $27.44M | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $13.43M | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $27.58M | +2.2% |
| Q4 FY2022 | Dec 31, 2022 | $27.44M | – |
| Q3 FY2022 | Sep 30, 2022 | $27.29M | – |
| Q2 FY2022 | Jun 30, 2022 | $27.15M | – |
| Q1 FY2022 | Mar 31, 2022 | $26.99M | +93.3% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $13.96M | +376.9% |
| Q1 FY2020 | Mar 31, 2020 | $13.69M | – |
| Q4 FY2019 | Dec 31, 2019 | $13.43M | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $2.93M | – |
See a number that looks wrong?